相关实验视频

Updated: Jun 15, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

多发性硬化症的细胞和分子证据诊断和治疗挑战

Zuber Khan¹, Ghanshyam Das Gupta², Sidharth Mehan¹

¹Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, IK Gujral Punjab Technical University, Jalandhar 144603, India.

Journal of clinical medicine

|July 14, 2023

概括

在印度,诊断和治疗多发性硬化症 (MS) 是一个挑战,因为意识有限,专家不足,药物成本高. 解决这些问题对于改善印度MS患者的护理至关重要.

科学领域:

神经学神经学
免疫学免疫学免疫学
公共卫生公共卫生

背景情况:

多发性硬化症 (MS) 是一种影响中枢神经系统的慢性自身免疫性疾病,在印度的患病率越来越高.
在印度,诊断和治疗多发性硬化症面临重大障碍,影响患者的治疗结果.

研究的目的:

检查印度背景下在多发性硬化症的检测和治疗中遇到的具体困难.
确定阻碍印度MS有效管理的关键因素.

主要方法:

该研究涉及对印度MS诊断和治疗现有挑战的审查.
分析的重点是诸如医疗保健专业人员和公众意识,专家可用性,药物可用性和治疗方案标准化等因素.

主要成果:

主要挑战包括公众和医疗保健专业人员对MS的认识较低,神经病学家短缺,以及MS药物的高成本使其无法获得.
缺乏标准化的治疗方案和专门的诊断工具,进一步使准确的诊断和监测变得复杂.
印度的人口多样性带来独特的遗传和分子挑战,影响治疗反应.

结论:

改善印度的MS诊断和治疗需要提高意识和教育,制定标准化的护理协议,并增加对研究和基础设施的投资.
解决这些多方面的问题对于更好的管理和改善印度MS患者的治疗结果至关重要.

关键词:

自身免疫反应自身免疫反应生物标志物生物标志物疾病修饰剂是疾病修饰剂.多发性硬化症多发性硬化症神经退行症的神经退行症

更多相关视频

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

相关概念视频

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...